Spinner CD; Barton J; Biever P; Klein M; Rieg S; Schneider J; Thoden J; Wagner D; Kern WV
Dtsch Med Wochenschr 2021[Feb]; 146 (3): 162-166 PMID33513649show ga
Corticosteroids have been found as useful adjunctive therapy in patients with various infections and hyperinflammation-associated disease. They are recommended in practice guidelines for patients with tuberculous and pneumococcal meningitis and patients with immune reconstitution syndrome associated with antiretroviral therapy. A new indication is severe COVID-19. Evidence from clinical trials is insufficient to allow the routine use of steroids among patients with septic shock, community-acquired pneumonia or tuberculous pericarditis.